🇺🇸 FDA
Patent

US 10173985

Aminoindazole derivatives as sodium channel inhibitors

granted A61KA61K31/416A61K31/437

Quick answer

US patent 10173985 (Aminoindazole derivatives as sodium channel inhibitors) held by Almirall, S.A. expires Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Almirall, S.A.
Grant date
Tue Jan 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/416, A61K31/437, A61K31/4439, A61K31/454